abstract |
The present application relates to substituted 4-aryl-1,4-dihydro-1,6-naphthyridines of the formula (I): (see formula I) wherein Ar, R1, R2, R3 and R4 are as defined herein, a process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders. |